Peptides from Paracoccidioides brasiliensis GP43 inhibit macrophage functions and inflammatory response

Adriana Y C Konno1, Juliana T Maricato, Fabiana T C Konno

  • 1Universidade Federal de São Paulo - UNIFESP, Department of Microbiology, Immunology and Parasitology, Discipline of Immunology, São Paulo, Brazil.

Microbes and Infection
|November 26, 2008
PubMed

Insights

Two peptides from the major antigen gp43 of Paracoccidioides brasiliensis were found to inhibit macrophage functions and reduce inflammation. These findings offer potential therapeutic targets for paracoccidioidomycosis (PCM).

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the fungus Paracoccidioides brasiliensis (Pb).
  • The major antigen gp43, a 43-kDa glycoprotein, plays a role in fungal evasion, granuloma formation, and immune response.
  • Understanding gp43 epitopes is crucial for developing targeted therapies against PCM.

Purpose of the Study:

  • To investigate specific epitopes within gp43 that can inhibit macrophage functions and inflammatory responses.
  • To identify potential therapeutic peptides for managing Paracoccidioides brasiliensis infections.

Main Methods:

  • Synthesis and testing of various gp43 peptides on bone marrow-derived macrophages.
  • Assessment of phagocytic activity after challenge with zymosan or Pb cells.
  • Analysis of nitric oxide (NO), hydrogen peroxide (H2O2), and TNF-alpha release.
  • In vivo evaluation of anti-inflammatory properties using Mycobacterium bovis bacillus Calmette-Guérin (BCG) and Pb cells.

Main Results:

  • Two surface-expressed peptides, P4 and P23, significantly decreased macrophage phagocytic index.
  • Both P4 and P23 inhibited NO release while enhancing H2O2 release from stimulated macrophages.
  • In vivo studies confirmed that these peptides possess both non-specific and specific anti-inflammatory properties.

Conclusions:

  • Specific gp43-derived peptides (P4 and P23) modulate macrophage function and exhibit anti-inflammatory effects.
  • These peptides represent promising candidates for novel therapeutic strategies against paracoccidioidomycosis.
  • Further research into these epitopes could lead to new treatments for fungal infections.